Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

NCT00098917 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: autologous tumor cell vaccine
DRUG: therapeutic autologous dendritic cells
PROCEDURE: adjuvant therapy
PROCEDURE: biological therapy
PROCEDURE: conventional surgery
PROCEDURE: surgery
PROCEDURE: tumor cell derivative vaccine
PROCEDURE: vaccine therapy

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]